RILASTIL'S SAFETY
TESTSDERMATOLOGICALLY TESTED FORMULAS
The product undergoes a Patch Test, a diagnostic method used to identify whether a substance that comes in contact with the skin is causing contact dermatitis. The product is applied to an adhesive plaster and affixed to a localized area of the skin. The dermatological control is carried out after 24 or 48 hours.
MICROBIOLOGICALLY TESTED FORMULAS
Every lot of products undergoes a test to detect the presence of any micro-organism and guarantee its compliance with the European Pharmacopoeia requirements.
OPHTHALMOLOGICALLY TESTED FORMULAS
The ophthalmic test is carried out to evaluate the degree of tolerance of the cosmetic preparations that will be used in the periocular area. The product is used on a daily basis over a specified time. The cosmetic tolerance is defined on the basis of the clinical evaluation of an eye doctor, who determines the onset of anomalies in the eye and records any adverse reaction reported by the volunteers.
HYPOALLERGENIC FORMULAS
Product formulated to minimize the risk of allergy. The product undergoes a "Repeated Insult Patch Test” (HRIPT)", a test to determine the skin allergic response, which is repeated over time. The product is applied to an adhesive plaster and affixed to a localized area of the skin. The application is repeated 9 times during three consecutive weeks under dermatological control.
NON COMEDOGENIC FORMULAS
The test allows to evaluate whether using the product daily may develop comedones, which may cause the occlusion of the sebaceous follicle, thus leading to the appearance of skin imperfections.

©RILASTIL